Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$151.22 USD
+1.31 (0.87%)
Updated May 13, 2024 04:00 PM ET
After-Market: $151.20 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Brokerage Reports
0 items in cart
Johnson & Johnson [JNJ]
Reports for Purchase
Showing records 1 - 20 ( 499 total )
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Menin Inhibitors Carving Out a Niche in Leukemias: Rationale, Opportunities, and Candidates
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 12124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 1124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 12123
Provider: Stock Traders Daily
Analyst: Research Department
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Solid Tumors - Week Ended November 24.
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Johnson & Johnson
Industry: Large Cap Pharmaceuticals
Optimized Entry and Exit Levels for JNJ 112123
Provider: Stock Traders Daily
Analyst: Research Department